Speak Up, Part 2

Baum, Neil
August 2011
Pharmaceutical Representative;Aug2011, Vol. 41 Issue 8, p23
In this article, the author offers tips on how pharmaceutical representatives can get audience attention during speaker programs. He states that sharing a personal experience is a strong way to communicate with the audience during these meetings. He also adds that it is important for speakers to understand the audience's wants such as statistics on medical issues and practice productivity of the pharmaceutical company.


Related Articles

  • Countering the AIG Effect. Hosansky, Tamar // Medical Meetings;Jun2009, Vol. 36 Issue 4, p34 

    The article focuses on the impact of increased public scrutiny of incentives and corporate events on the pharmaceutical meetings sector, as discussed during a summit for senior-level corporate planners at the Pharmaceutical Meeting Management Forum in 2009. According to one planner, her company...

  • A PLAN FOR REACTION. Castagnoli, William G. // Medical Marketing & Media;Jan2003, Vol. 38 Issue 1, p52 

    Presents several ideas from communications and media leaders on ways to solve public relations problems faced by the pharmaceutical industry in the U.S. Importance of educating decision-makers and consumers on the benefits of a research-based industry; Emphasis on regaining physicians' loyalty;...

  • PR View. Durand, Michael // Medical Marketing & Media;Apr2003, Vol. 38 Issue 4, p30 

    Discusses ways in which the drug industry can improve its image with the public. View of the industry as a brand; Creation of a national education program for journalists; Industry's image with legislators and physicians; Recommendation of courting regional papers.

  • PR View. Lampert, Steve // Medical Marketing & Media;Jul2003, Vol. 38 Issue 7, p36 

    Presents views on the scope of public relations practice in pharmaceutical companies. Advantages of affiliating with regional and local chapters of advocacy groups; Relations with mass media practitioners; Realization of company's communication goals through partnership with local organizations.

  • The Holmes Report.  // Pharmaceutical Executive;Mar2002, Vol. 22 Issue 3, p53 

    Comments on the public relations industry by Paul Holmes. Discussions on the pharmaceutical industry; Implication of the case for healthcare reform; Discussions on the reputation of corporation regarding valuable tools for attracting shareholders.

  • Client's View.  // Pharmaceutical Executive;Mar2002, Vol. 22 Issue 3, p58 

    Comments on the public relation related to pharmaceutical industry. Establishment of disciplines of medical education, professional and consumer advertising; Impact of professional communication on appropriate product use; Details on the lifecycle of prescription medication.

  • Media Lens. Gomez, Max // Pharmaceutical Executive;Mar2002, Vol. 22 Issue 3, p64 

    Examines the on public relation related to pharmaceutical industry. Illustration on the effective way to attack the disease; Emphasis on building anticipatory relationships with print and television reporters; Importance of drug education. INSET: Animating Anthrax.

  • Public Relating. Koberstein, Wayne // Pharmaceutical Executive;Nov2002, Vol. 22 Issue 10, p16 

    Focuses on the importance of effective public relations in the pharmaceutical industry. Employment of public relations to support corporate and product branding; Need for pharmaceutical companies to listen to criticisms outside and within the industry.

  • Video Pumps Up PR. Simon, Doug // Pharmaceutical Executive;Nov2002, Vol. 22 Issue 10, p144 

    Outlines a decision process that will help pharmaceutical public relations practitioners decide whether to produce a video news release, a b-roll or a satellite media tour. Factors to consider when deciding whether to provide stations with pre-produced video or a live interview opportunity. ...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics